Re: Engagement AgreementEngagement Agreement • May 9th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionThis letter agreement (the “Agreement”) confirms the terms and conditions that will govern the Provention Bio, Inc., a Delaware corporation (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”), engagement (the “Engagement”) of MDB Capital Group, LLC (together with its affiliates, “MDB”) as the Company’s exclusive financial advisor and placement agent in connection with an offering or series of offerings of Company securities.
Re: Engagement AgreementEngagement Agreement • September 21st, 2017 • Cue Biopharma, Inc. • California
Contract Type FiledSeptember 21st, 2017 Company JurisdictionThis letter agreement (the “Agreement”) confirms the terms and conditions that will govern ImaGen Biopharma, Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”) engagement (the “Engagement”) of MDB Capital Group, LLC (together with its affiliates, “MDB”) as the Company’s exclusive financial advisor and placement agent in connection with an offering or series of offerings of Company securities.
Re: Engagement AgreementEngagement Agreement • December 22nd, 2015 • Pulse Biosciences, Inc. • California
Contract Type FiledDecember 22nd, 2015 Company JurisdictionThis letter agreement (the “Agreement”) confirms the terms and conditions that will govern Electroblate, Inc. (together with its affiliates, subsidiaries, predecessors, and successors, the “Company”) engagement (the “Engagement”) of MDB Capital Group, LLC (together with its affiliates, “MDB”) as the Company’s exclusive financial advisor and placement agent in connection with an offering or series of offerings of Company securities.